Status:
COMPLETED
The Belgian Diabetes in Pregnancy Follow-up Study
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
University Hospital, Antwerp
Onze Lieve Vrouw Hospital
Conditions:
Gestational Diabetes
Type2 Diabetes
Eligibility:
All Genders
3+ years
Brief Summary
Gestational diabetes (GDM) is a form of diabetes that develops during pregnancy. GDM is associated with increased risks for pregnancy complications such as macrosomia s and preterm delivery. Women wit...
Eligibility Criteria
Inclusion
- Mothers who participated in the completed BEDIP-N study and received both the GCT as the OGTT during pregnancy
- Offspring born at the time of participation in the BEDIP-N study
Exclusion
- Mothers:
- Current pregnancy
- Treatment that influences glycaemic status such as high dose corticoids.
- History of bariatric surgery
- gastro-intestinal surgery changing the absorption of glucose (Billroth II)
- A normal study visit will not be possible (incompliance, psychiatric problems…)
- Diagnosed with type 1 diabetes or the presence of auto-immune antibodies for type 1 diabetes
- Offspring:
- Treatment that influences glycaemic status such as high dose corticoids.
- A normal study visit will not be possible (incompliance, psychiatric problems…)
- Diagnosed with type 1 diabetes or the presence of auto-immune antibodies for type 1 diabetes
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 23 2023
Estimated Enrollment :
630 Patients enrolled
Trial Details
Trial ID
NCT04429958
Start Date
January 25 2021
End Date
October 23 2023
Last Update
November 1 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
OLV-Alast
Aalst, Belgium
2
UZA
Antwerp, Belgium
3
OLV-Asse
Asse, Belgium
4
Imelda Bonheiden
Bonheiden, Belgium